Hypoxia-induced expression of VEGF in the organotypic spinal cord slice culture

NeuroReport

Volumn 22, Issue 2, 2011, Pages 55-60

  An, Sung Su ^a   Pennant, William A ^a   Ha, Yoon ^a   Oh, Jin Soo ^a   Kim, Hyo Jin ^a   Gwak, So Jung ^a   Yoon, Do Heum ^a   Kim, Keung Nyun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Gene therapy; Hypoxia inducible gene expression system; Organotypic spinal cord slice culture

Indexed keywords

VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HYPOXIA; IN VITRO GENE TRANSFER; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIMIAN VIRUS 40; SPINAL CORD; SPINAL CORD INJURY; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANOXIA; ASTROCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79551518196     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283418b00     Document Type: Article

References (14)

1. Lee RJ, Springer ML, Blanco-BoseWE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000; 102:898-901.
2. Isner JM. Myocardial gene therapy. Nature 2002; 415:234-239.
3. Brockington A, Lewis C, Wharton S, Shaw PJ. Vascular endothelial growth factor and the nervous system. Neuropathol Appl Neurobiol 2004; 30:427-446.
4. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and schwann cell proliferation in the peripheral nervous system. J Neurosci 1999; 19:5731-5740.
5. Zacharek A, Chen J, Cui X. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab 2007; 27:1684-1691.
6. Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. BioEssays 2004; 26:943-954.
7. Lee M, Lee ES, Kim YS, Choi BH, Park SR, Park HS, et al. Ischemic injuryspecific gene expression in the rat spinal cord injury model using hypoxiainducible system. Spine 2005; 30:2729-2734.
8. Choi BH, Ha Y, Ahn CH, Huang X, Kim JM, Park SR, et al. A hypoxiainducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury. Neurosci Lett 2007; 412:118-122.
9. Stavridis SI, Dehghani F, Korf HW, Hailer NP. Characterisation of transverse slice culture preparations of postnatal rat spinal cord: preservation of defined neuronal populations. Histochem Cell Biol 2005; 123:377-392.
10. Jin H, Liu ML, Kim HA, Lee M, An S, Oh J, et al. Role of the oxygendependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy. Spine 2009; 34:952-958.
11. Lee M, Rentz J, Bikram M, Han S, Bull DA, Kim SW. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther 2003; 10:1535-1542. (Pubitemid 37063258)
12. Choi UH, Ha Y, Huang X, Park SR, Chung J, Hyun DK, et al. Hypoxiainducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model. J Neurosurg Spine 2007; 7:54-60.
13. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in-vitro ischemia. Proc Natl Acad Sci U S A 2000; 97:10242-10247.
14. Brockington A, Lewis C,Wharton S. Vascular endothelial growth factor and the nervous system. Neuropathol Appl Neurobiol 2004; 30:427-446.